The application of the SVM‐RFE algorithm revealed that FAT1, FGF3, FGF12, and FGF19 expressions; neutrophil count; and M stage were most significantly associated with prognosis in ESCC patients (Figure 4a). This evidence concerns the gene FGF12 and esophageal squamous cell carcinoma.